FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A.

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

FF

IT0005215329

Food Processing

Market Closed - Borsa Italiana Other stock markets 09:14:59 07/05/2024 pm IST			5-day change	1st Jan Change
8.7 ^EUR	0.00%		+0.93%	-0.80%

30/04	Emak best performer; Bialetti trailing.	AN
02/04	Fine Foods narrows loss in 2023; up 22 percent in revenue	AN

Fine Foods purchased 3,476 shares of its own common stock

July 24, 2023 at 11:10 pm IST

(Alliance News) - Fine Foods & Pharmaceuticals NTM Spa reported Monday that it purchased 3,476 of its own ordinary shares between July 17 and July 21.

The shares were taken over at an average unit price of EUR8.0519, for a total consideration of EUR27,988.39.

To date, the company holds 1.0 million treasury shares, or 4.1 percent of its share capital.

Fine Foods & Pharmaceuticals NTM stock Monday closed in the green by 0.8 percent at EUR7.99 per share.

By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Latest news about Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Emak best performer; Bialetti trailing.	30/04	AN
Fine Foods narrows loss in 2023; up 22 percent in revenue	02/04	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Fine Foods & Pharmaceuticals NTM takes over 2,100 shares of its own stock	05/02	AN
Fine Foods & Pharmaceuticals purchases 1,600 treasury shares	29/01	AN
Fine Foods & Pharmaceuticals purchases 2,000 treasury shares	22/01	AN
Fine Foods & Pharmaceuticals NTM takes over 2,300 of its own shares	15/01	AN
Fine Foods & Pharmaceuticals NTM takes over 2,000 shares of its own stock	08/01	AN
Fine Foods & Pharmaceuticals NTM acquires 2,159 shares of its own stock	19/12	AN
Fine Foods & Pharmaceuticals purchases 2,000 treasury shares	11/12	AN
More buy orders on stock markets; ERG on top	15/11	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	15/11	CI
Fine Foods & Pharmaceuticals improves loss; on revenue and Ebitda	14/11	AN
Fine Foods & Pharmaceuticals NTM takes over 2,400 shares of its own stock	24/23/24	AN
Fine Foods & Pharmaceuticals NTM takes over 2,137 shares of its own stock	16/23/16	AN
Fine Foods & Pharmaceuticals NTM takes over 3,200 shares of its own stock	09/23/09	AN
Fine Foods & Pharmaceuticals purchases shares for EUR38,000	02/23/02	AN
Fine Foods & Pharmaceuticals NTM improves half-year loss	13/23/13	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	13/23/13	CI
Fine Foods & Pharmaceuticals NTM acquires more than 2,000 shares of its own stock	31/23/31	AN
Fine Foods purchased 3,476 shares of its own common stock	24/23/24	AN
Pininfarina bullish; Fine Food trailing.	21/23/21	AN
Fine Foods has purchased more than 2,500 shares of its own common stock	17/23/17	AN
Fine Foods & Pharmaceuticals NTM takes over 1,600 shares of its own stock	10/23/10	AN
Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) commences an Equity Buyback Plan for 20% of its issued share capital,under the authorization approved on May 9, 2023.	10/23/10	CI

Chart Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Duration

Period

Chart Fine Foods & Pharmaceuticals N.T.M. S.p.A.

More charts

Fine Foods & Pharmaceuticals NTM SpA, formerly Innova Italy 1 SpA, is an Italy-based pharmaceutical company. It is specialized in the manufacturing of pharmaceutical products for third parties. The Company manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

Sector

Food Processing

Calendar

15/05/2024 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.7 EUR

Average target price

12.25 EUR

Spread / Average Target

+40.80%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A.	-0.80%	230M
ZHEJIANG NHU COMPANY LTD.	+16.75%	8.43B
BELLRING BRANDS, INC.	+3.59%	7.65B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+12.04%	6.65B
BYHEALTH CO., LTD	-5.81%	3.78B
THE SIMPLY GOOD FOODS COMPANY	-5.81%	3.73B
XIAMEN KINGDOMWAY GROUP COMPANY	+0.98%	1.39B
SIRIO PHARMA CO., LTD.	+19.97%	1.04B
HERBALIFE LTD.	-34.08%	1.01B
USANA HEALTH SCIENCES, INC.	-16.53%	861M

Special Foods & Wellbeing Products

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Equities

FF

IT0005215329

Food Processing

Fine Foods purchased 3,476 shares of its own common stock

Latest news about Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Chart Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Company Profile

Income Statement Evolution

Ratings for Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Special Foods & Wellbeing Products